{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:19:41Z","timestamp":1784647181601,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":5333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.exphem.2007.07.002","type":"journal-article","created":{"date-parts":[[2007,8,31]],"date-time":"2007-08-31T07:14:53Z","timestamp":1188544493000},"page":"1723-1727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy"],"prefix":"10.1016","volume":"35","author":[{"given":"Francis H.","family":"Grand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameena","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.P.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2007.07.002_bib1","series-title":"Hematologic Malignancies: Myeloproliferative Disorders","first-page":"219","article-title":"BCR-ABL negative chronic myeloid leukaemia","author":"Cross","year":"2006"},{"key":"10.1016\/j.exphem.2007.07.002_bib2","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1182\/blood-2002-02-0420","article-title":"Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors","volume":"100","author":"Kottaridis","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.07.002_bib3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2174\/1381612043452604","article-title":"Small molecule FLT3 tyrosine kinase inhibitors","volume":"10","author":"Levis","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.exphem.2007.07.002_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1535-6108(02)00069-7","article-title":"Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412","volume":"15","author":"Weisberg","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2007.07.002_bib5","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood-2003-11-3775","article-title":"Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia","volume":"103","author":"Smith","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.07.002_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/380152a0","article-title":"A comprehensive genetic map of the human genome based on 5,264 microsatellites","volume":"380","author":"Dib","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2007.07.002_bib7","doi-asserted-by":"crossref","first-page":"7216","DOI":"10.1158\/0008-5472.CAN-04-2005","article-title":"p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder","volume":"64","author":"Grand","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2007.07.002_bib8","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1182\/blood.V97.8.2434","article-title":"Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies","volume":"97","author":"Yamamoto","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.07.002_bib9","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1074\/jbc.M308743200","article-title":"Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1","volume":"279","author":"Heath","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2007.07.002_bib10","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1182\/blood-2002-06-1800","article-title":"A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657","volume":"101","author":"Sohal","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.07.002_bib11","first-page":"701","article-title":"Targeting protein kinases in cancer therapy","volume":"5","author":"Fabbro","year":"2002","journal-title":"Curr Opin Drug Discov Dev"},{"key":"10.1016\/j.exphem.2007.07.002_bib12","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1158\/1078-0432.CCR-05-0358","article-title":"CHIR-258: a potent inhibitor of FLT3 kinase in experimental tumor xenograft models of human acute myelogenous leukemia","volume":"11","author":"Lopes de Menezes","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2007.07.002_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/sj.bmt.1701224","article-title":"Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors","volume":"21","author":"van Rhee","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2007.07.002_bib14","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/sj.leu.2404266","article-title":"FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation","volume":"20","author":"Vu","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2007.07.002_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1385\/JMN:17:1:59","article-title":"A novel isoform of beta-spectrin II localizes to cerebellar Purkinje-cell bodies and interacts with neurofibromatosis type 2 gene product schwannomin","volume":"17","author":"Chen","year":"2001","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.exphem.2007.07.002_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.exphem.2007.01.018","article-title":"Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells","volume":"35","author":"Moore","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2007.07.002_bib17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood-2006-05-024018","article-title":"Activation mechanisms of STAT5 by oncogenic Flt3-ITD","volume":"110","author":"Choudhary","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.07.002_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood-2002-11-3441","article-title":"Sensitivity toward tyrosine kinase inhibitors varies between different activating mutations of the FLT3 receptor","volume":"102","author":"Grundler","year":"2003","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X07004249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X07004249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:24:40Z","timestamp":1759566280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X07004249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0301472X07004249"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2007.07.002","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2007.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}